Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 19, 2018
Pharmacy Choice - Pharmacy News - February 19, 2018

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
2/19/18 - AstraZeneca's IMFINZI approved for Stage III nsclc
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration has approved Imfinzi for the treatment of patients with unresectable Stage III non-small cell lung cancer whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.
2/19/18 - AstraZeneca: Imfinzi Receives FDA Approval To Treat Unresectable Stage III NSCLC
LONDON- AstraZeneca PLC and MedImmune announced the. US FDA has approved Imfinzi for the treatment of patients with unresectable Stage III non-small cell lung cancer whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. The approval is based on the positive PFS data from the Phase III PACIFIC trial
2/19/18 - Embrace by Empatica is the world's first smart watch to be cleared by FDA for use in Neurology
By a News Reporter-Staff News Editor at Clinical Trials Week-- Empatica Inc has received clearance from the FDA for Embrace, its award-winning smart watch. Embrace uses AI to monitor for the most dangerous kinds of seizures, known as "grand mal" or "generalized tonic-clonic" seizures, and send an alert to summon caregivers' help. In a multi-site cl
2/19/18 - Grifols HyperRAB® rabies immune globulin [human] 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection
By a News Reporter-Staff News Editor at Pharma Business Week-- Grifols, a leading global producer of plasma-derived medicines and provider of a variety of postexposure prophylaxis and immune globulin products for patients, has received approval from the U.S. Food& Drug Administration for a new higher potency formulation of its HyperRAB ® rabies im
2/19/18 - Novartis receives FDA approval for Cosentyx® label update to include moderate to severe scalp psoriasis
By a News Reporter-Staff News Editor at Pharma Business Week-- Novartis announced that the US Food and Drug Administration has approved a label update for Cosentyx ®, the first interleukin-17A antagonist approved to treat moderate to severe plaque psoriasis.1 The updated label includes Cosentyx data in moderate to severe scalp psoriasis- one of th
2/19/18 - Novo Nordisk Launches Ozempic® and Fiasp®, Expanding Treatment Options for Adults with Diabetes
By a News Reporter-Staff News Editor at Clinical Trials Week-- Novo Nordisk announced the availability of two new diabetes medications, Ozempic ® injection 0.5 mg or 1 mg and Fiasp ® 100 Units/mL at pharmacies across the United States. Both medications received approval from the U.S. Food and Drug Administration in 2017 and represent the latest a

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415